Name: Stroke 2023
Start: 2023-10-12
End: 2023-10-14
Location: France

Renowned Speakers

We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.

Dr. Richard Anderson

University of Ottawa, Canada

Dr. Julia Fagen

University of North Carolina School of Medicine, USA

Prof. Annamaria Micheal

University of Foggia, Italy

Dr. Robert Felix

Anglia Ruskin University, UK

Conference Information

Welcome Message

Dear conference visitors, researches, scientists and colleagues!

We are glad to invite you all to our 12th International Conference on Neurodegenerative Disorders and Stroke, which is to be held October 12–14, 2023, in Paris, France, and which includes keynote presentations, poster presentations, oral talks, and exhibitions.

Stroke 2023 brings together scientists, researchers, professors, Stroke professionals, postdoctoral fellows, and students from the field of psychiatry department, Neurology and Neurodegenerative Disorders from all over the world, giving them the chance to report, share, and discuss scientific questions, successes, and challenges in this field.

The innovation theme for this year is "Prism of Possibilities to Diagnose Stroke Disorders," which opens the door for information to be gathered. Stroke2023's goal is to talk about and present noteworthy experiences with various Stroke and Neurodegenerative Diseases treatments.

It provides the chance to network with well-known personalities in research and industry and meet them in person. This global gathering will have a significant impact because innovators will speak out most forcefully on the most crucial issues.

Participants will benefit from receiving perks, including a certificate from the OCM, abstract publication on the conference website, networking opportunities with international experts, and the chance to purchase physical copies of the conference proceedings.

We look forward to seeing you at the "City of Light" in Paris in October for Stroke2023.

Regards,

Alice Morgan | Stroke 2023

Market Analysis

Global Stroke Management Market

An extensive analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market is provided in the research report Global Stroke Management Market Status, Trends and COVID-19 Impact Report 2021, a COVID-19 Outbreak Impact research report added by Report Ocean. It charts the market's historical and anticipated geographic growth. It compares the market to other markets and situates it within the larger Stroke Management Market. Market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Digital Evidence Management market size forecast, market data and graphs and statistics, tables, bar & pie charts, and many more are available for business intelligence.

In 2021, the market for Stroke Therapy Management in the world was worth US$ 34206.67 million. By 2030, the size of the global Neurology Management Market is anticipated to reach US$ 67871.95 million, expanding at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030.

Impact of Covid-19 on Stroke Management Market

The coronavirus (COVID-19)

Due to the cause of COVID-19, the need for Stroke diagnostic and monitoring equipment decreased. Device manufacturing facilities were shut down during the global shutdown. For instance, the patient admission, treatment, and discharge volumes for acute Stroke Therapy in central and south Texas have decreased, according to statistics from the National Institute of Health.

The market participants' financial disaster was brought on by this shutdown. This further caused problems with the import and export of gadgets between the nations. Overall, the impact of COVID-19 on the Neuroscience Management Market was found to be quite unfavorable. This was ascribed to a decline in the demand for tools used in the diagnosis of Stroke illness. Furthermore, due to a decline in the number of Transient Ischemic Attack Stroke patients being admitted to hospitals, market participants have decreased their investment in raw materials and resources.

A predicted CAGR of 8% from 2022 to 2030 would cause the market for diagnostic and treatment goods for Neurological Disorders to rise from its estimated value of USD 32.69 billion in 2021 to USD 65.45 billion by 2030.

Key driver of market expansion:

More individuals are at risk of having a Stroke .
A stronger understanding of patients.
A rise in medical costs of Neurology.
A significant elderly population.

Stroke Diagnostic and Treatment Market

The global market for Stroke diagnostic and treatment products were estimated to be worth USD 32.69 billion in 2021 and is expected to reach USD 65.45 billion by 2030, growing at a projected CAGR of 8% from 2022 to 2030.

Why Stroke?

Future of Global Stroke Diagnostic and Therapeutic Market

Important businesses like Medtronic plc and Cerebrotech Medical Systems, Inc. are pursuing profitable expansion by embracing tactics like mergers and acquisitions and significant investments in the industrial infrastructure that are anticipated to drive global market growth in Neuroscience in the near future. This trend is probably going to persist, which will boost the targeting industry's expansion in the anticipated time frame. 2019 saw the launch of the Vercise Gevia Deep Brain Disorders and Vercise Primary Cell by market leader Boston Scientific Corporation.

Stroke Overview in Europe

In 2017, 438,000 deaths in Europe were attributed to Stroke, or 8% of all fatalities. Stroke Therapy also has a negative effect on the lives of many survivors by weakening a number of functions, making it more challenging for survivors to do daily duties. Ischemia Stroke is one of the leading causes of disability and increased use of health and social-care resources, costing 798 billion euros or 8% of the cost of Brain Disorders.

Leading competitors in the market:

Neural Analytics
Cordis Corporation
Cerebrotech Medical Systems, Inc.
Koninklijke Philips N.V.
Medtronic plc.
Boston Scientific Corporation
GE Healthcare
Medfield Diagnostics
Samsung Neurological
NIRX
Gower labs
Siemens AG
Genentech Inc.
Merck & Co., Inc.
Hyperfine MRI
Stryker Corporation
Abbott Laboratories

About Conference

Every year, neurologists, Stroke Therapy experts, and other associated professionals gather at Stroke Conference to discuss advancements in the diagnosis, treatment, and rehabilitation of Neurological illnesses.

For Stroke clinicians, neurologists, researchers, and policy makers, the Stroke2023 will cover the most recent and cutting-edge issues in Neurogenerative disorders and Neurology Disorders. The scientific program has been improved to foster greater interaction, debate, and learning that emphasizes basic, clinical, and translational sciences as they advance towards a better understanding of the pathophysiology of Neurodegenerative disorders and Stroke with the aim of creating more efficient treatments.

The ability to network with colleagues in the Neuroscience field from across the world with a variety of specialties and experiences is another benefit of the Stroke Conference 2023.

We look forward to hearing from you and greeting you in France.

Why Should Attend?

Meet your target audience and invite them to learn more about your offerings
Putting Your Organization's Work on the World Stage
Discuss and resolve problems in your field with the help of experts
Cooperate with Sector Specialists Study the ICCPS Speakers
Award for the best justice poster presentation and chairing or co-chairing a session
Meeting new individuals from over 22 different countries
Expanding your Knowledge Base Competitive Benefit
Possibility to Participate and Sponsor
Expand your knowledge beyond your area of expertise or interest.
A presenters' participation certificate

Past Conference Report

The"10th International Conference on Neurodegenerative Diseases and Stroke" was successfully held in Rome, Italy on February 14–15, 2022 as a Hybrid event thanks to the excellent assistance of our organizing committee.

First and foremost, we want to express our gratitude for your trust in us and for taking part in Stroke2022, a global conference devoted to many facets of Stroke Surgery, Neurology, and Neuroscience. There are many ways we can thank you for putting together such a spectacular online event for Stroke2022.We couldn't have achieved Stroke2022 without your unwavering belief in our organization and support, which has advanced to new levels in the fields of Stroke, Neurology, and Neuroscience.

Pulsus conferences is pleased to announce the "12th International Conference on Neurodegenerative Diseases and Stroke," which will take place on October 12–14, 2023, in Paris, France, in light of the positive reception and comments we got at this event.

To make this activity a success once more, we would appreciate your pleasant participation, constructive involvement, and support.

Some of the Influential Speakers from Our Past Conference Series:

Keynote Speakers

Catherine M Cahill | Harvard Medical School | USA

Radu Mutihac | University of Bucharest | Romania

David J. Dickoff | The Mount Sinai Hospital | USA

Sinerik Ayrapetyan| UNESCO Chair in Life Sciences Yerevan | Armenia

Plenary Speakers

Jean Roch Alliez|CHP Clairval|France

Szu-Yi Chou | Taipei Medical University |Taiwan

DMD Noura Hasan | Mansoura University | Egypt

Felician Stancioiu | Bio-Forum Foundation | Romania

Sinjan Choudhary | University of Mumbai | India

Mai M. Abdelmoaty | University of Nebraska Medical Center | USA

Felipe Gomes de Barros Pontes | Federal University of Sao Paulo | Brazil

Ni Made Dwita Pratiwi | Sanglah National Public Hospital | Indonesia

Ishrat Jahan | Aligarh Muslim University | India

Sessions

The Stroke 2023 scientific program offers keynote forums, oral talks, poster presentations, young research forums, and exhibitions for the dissemination of most recent advancements through the following topics.

Stroke
Neurodegenerative Disorder
Innovations in Stroke Diagnosis
Stroke Surgery
Stroke and Mental Health
Stroke Nursing
Neonatal and Pediatrics Stroke
Risk Factors, Prevention of stroke, And stroke Awareness
Cerebral Circulation and Associated Diseases
Case Report and Clinical Trial Results
Stroke Recovery and Rehabilitation
Stem Cell Therapy for Stroke
Robotic Device For Stroke
Stroke On Covid-19 Patients
Stroke and its Management
Stroke and Cardiovascular conditions
Current Advances in Stroke Prevention Strategies
Post-Stroke Cognitive Impairment
Stroke in Young Adults
Stroke Depression and Anxiety
Stroke and Vascular Dementia
Haemorrhagic stroke
Neurology
Ischemic stroke
Telemedicine in Stroke Care
Neurological disorders
Neuromuscular Disorders & Neurotherapy
Spine Disorders
Animal Models of Stroke
Brain and Neuromuscular conditions
Brain Pathology and Oncology Research
Neurosurgery

Neurodegenerative Disorder:

The market for Neurodegenerative Diseasess was valued at USD 45,441.30 million in the base year and is anticipated to grow at a CAGR of 6.93% over the next five years. The increased frequency of Neurological illnesses, greater public awareness, and a robust product pipeline for the treatment of Neurodegenerative Diseasess are the main market growth drivers. The prevalence of Neurological illnesses is anticipated to raise the need for therapies and efficient treatment options, which will support the expansion of the market for Neurodegenerative Diseasess.

Related Association:

Related Societies:

Related Journals:

Related Keywords:

Neuroimaging and Neurosonology:

According to research from future market insights, the market for brain imaging and Neuroimaging is expected to grow globally at a CAGR of 5.1% between 2022 and 2032, reaching a total of US$ 21,569.7 Million in 2032. (FMI). When a vascular aetiology is suspected, neurosonology offers a noninvasive way to examine the cervicocephalic circulation. We want to assess how well a vascular neurosonological test can identify an isolated acute vestibular condition.

Related Associations:

Related societies:

Related journals:

Related keywords:

Animal Models of Stroke

Stroke is a fatal illness with a high death rate. The most frequently used models for simulating Ischemic Stroke in humans include transient or permanent intraluminal thread occlusion, middle cerebral artery occlusion and thromboembolic models. Animal models are essential tools that can mimic Stroke processes and can be used for investigating mechanisms and developing novel therapeutic regimens.

Related Journals:

The Use of Animals Models for Stroke Research | A Review on Animal Models of Stroke | Quality and Validity of Large Animal Experiments in Stroke | Animal Models of Ischemic Stroke and Their Application in Clinical Research | Large Animals Ischemic Stroke Models | Pathophysiology and Treatment of Stroke | Animal Models of Focal and Global Cerebral Ischemia

Related Keywords:

Neuromuscular Disorders & Neurotherapy

A broad range of hereditary diseases known as Neuromuscular Disorders (NMDs) are defined by a loss of muscle functioning. There are several attempts being made to provide therapeutics, however none of the NMDs have a cure. Nonetheless, treatment methods are now being examined in clinical settings for a variety of illnesses.

An individual may occasionally experience extreme stress as a result of life's hustle and bustle, which can harm both his or her mental and physical health.

Related Associations:

American Association of Neuromuscular & Electrodiagnostic Medicine | Find a Neuromuscular Disease | Neuromuscular Disease Foundation | European Alliance of Neuromuscular Disorders Associations | The Finnish Neuromuscular Disorders Association | Association of Neurotherapy Chikitsa Padhati | Neurotherapy Treatment for Special Children | Association for Comprehensive Neurotherapy

Related Journals:

Related Societies:

Related Keywords:

Innovations in Stroke Diagnosis

Technological developments in surgical procedures, an ageing population, a rise in demand for less invasive treatments, and an increase in health care spending. According to information provided by the American College of Cardiology, around 1.2 million angioplasties were carried out annually in the United States as of November 2020.

In 2021, the market for Stroke diagnostic and therapeutic products was estimated to be worth USD 32.69 billion. By 2030, it is expected to have grown to USD 65.45 billion, with a compound annual growth rate (CAGR) of 8% expected from 2022 to 2030.

Related Associations:

Related Societies:

Related Journals:

Related Keywords:

Stroke Surgery

The global market for ischemic Stroke Surgery is expected to grow at a CAGR of 8.70% from 2022 to 2035 due to the adoption of technologically sophisticated technologies, increased desire for minimally invasive treatments, and a rise in sedentary lifestyles. The majority of the industry members projected positive increase in Ischemic Stroke surgical product sales in 2021 as supply chains gradually recovered and constraints were eased as a result of rising vaccination rates and a global drop in infection rates.

Related Associations:

Related Societies:

Related Journals:

Related Keywords:

Stroke and Its Types

Ischemic, hemorrhagic, and transient ischemic attacks (TIA) are the three types of Stroke that make up the Stroke Rehabilitation market. The global Stroke management market is dominated by the Ischemic Stroke segment due to increased healthcare awareness, rise in incidence of diabetes, surge in number of tobacco users, and growth in geriatric population.

The sort of treatment needed depends on the type of Stroke that occurs. Ischemic Stroke account for 87% of Stroke. In between 33% and 65% of cases, intracerebral hemorrhage results in mortality.

Related Associations:

Related Societies:

Related Journals:

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Multiple Sclerosis and Demyelinating Disorders | Multiple Sclerosis and Related Disorders | Neurological Sciences, Neurology and Therapy | Advances in Alzheimer's Disease, Alzheimer's and Dementia | American Journal of Neuroradiology | Annals of Child Neurology and Movement Disorders

Related Keywords:

Stroke Nursing

Extending a specialized nursing role after discharge from the hospital to provide outreach education and support to Neurological Disorder patients and carers is beneficial in improving recovery. The nursing role in Stroke services has been defined as "hands-on," with engagement in care coordination and patient-centered components (Burton and Gibbon, 2005).

Nursing Diagnosis,

In the presence of appropriate cerebral perfusion
Deficiency in physical mobility Impairment in communication
Sensory perception has been altered.
Inability to carry out everyday life tasks
Sucking difficulties
Inefficient coping

Related Associations:

Related Societies:

Related Journals:

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Multiple Sclerosis Demyelinating Disorders | Multiple Sclerosis and Related Disorders | Neurological Sciences, Neurology and Therapy | Advances in Alzheimer's Disease, Alzheimer's and Dementia | American Journal of Neuroradiology | Annals of Child Neurology and Movement Disorders.

Related Keywords:

Neonatal and Pediatric Stroke

Newborns between the ages of birth and 28 days are susceptible to neonatal Stroke Therapy. It affects one in every 2,500 full-term newborns, and preterm infants are more likely to get it than full-term infants. Strokes can happen even before birth. Infants who have convulsions or who are weak and unresponsive are frequently found to have neonatal Stroke shortly after delivery, and this is confirmed by Neuroimaging. Every year, one out of every 4,000 newborns and an extra two out of every thousand older children experience a pediatric Stroke .

Related Associations:

Related Societies:

Related Journals:

Related Keywords:

Risk Factors, Prevention of Stroke, And Stroke Awareness

Stroke risk assessment is the methodical process of assessing the possible risk of Stroke Therapy that could be associated with a planned activity. For the assessment of Stroke Surgery, several different tools are employed. Among them is the SRAT (Stroke Risk Assessment Tool). By keeping an eye on circulation issues, high blood pressure, high cholesterol, atrial fibrillation, and diabetes, Stroke prevention can be achieved.

Related Associations:

Related Journals:

Related Keywords:

Cerebral Circulation and Associated Diseases

The brain's blood vessels and blood flow are affected by a collection of disorders known as "cerebral circulation disease," which includes conditions that alter blood flow and these blood vessels. Problems with blood flow can result from blood vessel stenosis, thrombosis, embolism, and blood vessel rupture. The projected 157,803 fatalities in 2003 that were assumed to be brought on by cerebral circulation disease included 138,397 deaths in those 65 and older. Cerebral vascular disease is the most common fatal Neurological disorder in the United States. The cause of 10% of all Ischemic Stroke or around 40,000 of these occurrences annually, is intracranial atherosclerosis.

Related Associations:

Related Societies:

Related Journals:

Related Keywords:

Case Report and Clinical Trial Results

Case studies are essential for the creation of innovations and proposals for Stroke and Neurodegenerative illnesses. The causes, symptoms, treatments, and potential consequences are determined by the research. It focuses on the methods and advantages of case studies. Detailed Case studies are frequently used to describe individuals with uncommon, aberrant, or rare illnesses. The creation of novel clinical innovations and therapies benefits from the capacity to frame a Neurological problem from a case study.

The clinical trials market had a value of USD 39,710,28 million in the base year, and during the forecast period, it is anticipated to grow at a CAGR of 5.05%.

The high need for clinical trials in developing economies, rising pharmaceutical industry R&D investment, and an increase in the prevalence of illnesses are the main drivers of the market's expansion.

A growing number of disorders demand the use of more sophisticated and potent medications, which helps the market expand.

Related Association:

Related Society:

Related Journals:

Related Keywords:

Stroke Recovery and Rehabilitation

The market for Stroke Rehabilitation was estimated to be worth US$ 266.4 Mn in 2021, with a 9% predicted CAGR for the next ten years, indicating strong market growth.

Stroke Rehabilitation Market trends that would impact the expansion of the entire industry have been intricately analyzed in a study created by Future Wise Market Research. Also, it contains thorough details on the business's geographical expansion, market share, SWOT analysis, and profitability graph. Furthermore, the report provides details on the present positions of key market players in the study of this market's competitive landscape.

Related Associations:

Related Societies:

Related Journals:

Related Keyword:

Stem Cell Therapy for Stroke

From the early 2000s, stem cell therapies for Stroke have been the subject of clinical trials, and research suggests that these treatments are safe, practicable, and maybe effective. Yet, only 1% of all stem cell trials are clinical trials for Neurology disorders. Resources still go into clinical research (53-64 million US dollars, Phase 1-4) to find novel Stroke Therapy.

The information already available from finished Stroke trials, the significance of outcome reporting standards, and the part played by industry-led research in the creation of cell treatments for Stroke will be discuss in Stroke 2023.

Related Associations:

Related Journals:

Related Keywords:

Robotic Device for Stroke:

In the years ahead, the market for rehabilitation robots is anticipated to grow at a CAGR of 26.12%. (2021 - 2026). In European union, per year healthcare expenditure on Stroke Surgery is estimated at US$ 31.8 billion along with the loss of income for Stroke patients facing difficulty in daily activities. The most commonly used assistive device prescribed for Stroke Surgery survivors are Mobility Assistive Devices (MAD).

Rehabilitation Robots Market Top Player:

Cyberdyne Inc.
Ekso Bionics Holdings Inc.
Bionik Laboratories Corporation
Hocoma AG
Rehab-Robotics Company Limited

Related Associations:

Related Societies:

Related Journals:

Related keywords

Stroke on COVID-19 Patients:

The considerably increased risk of Stroke in COVID-19 carriers has generally been thought to be caused by immunological reactions to the virus. Using COVID-19, it was shown that the interplay of pre-existing vascular risk factors with the immune response results in an amplified, robust inflammatory response that eventually produces arterial thrombosis, occlusion, and Stroke .

As compared to non-COVID-19-infected individuals, those with SARS-CoV-2 arterial thrombosis experience poor outcomes despite receiving the most aggressive medicinal, endovascular, and microsurgical care, including Stroke Therapy, myocardial infarction, and peripheral artery thrombosis.

In this study, we give a brief introduction to SARS-CoV-2, the pathogen that caused the COVID-19 pandemic, and discuss the processes behind the coagulopathy linked to COVID-19. We conclude by talking about COVID-19's effects on ischemic Stroke with an emphasis on big vessel blockage.

Related Associations:

Related Societies:

Related Journals: